Related Experiment Video
Updated: Aug 1, 2025
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Combination of Novel Therapies and New Attempts in Anaplastic Thyroid Cancer
1Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Abstract:
Anaplastic thyroid cancer (ATC) is one of the most lethal human malignancies, and it is rapidly falling without any effective therapeutic options. Although radical surgery, radiotherapy, and chemotherapy are performed on patients, the curative effect is suboptimal, and the survival rate is still poor. The discovery of altered gene pathways involved in this aggressive disease has advanced, but molecular targeted drugs targeting these pathways are still in clinical trials. To date, there is no effective way to treat this disease, so it is particularly urgent to find new treatments. At present, multimodal therapy is gradually being applied in clinical practice, which provides a new possibility for prolonging the survival time and improving the prognosis of anaplastic thyroid carcinoma. In this study, we retrospectively analyzed the current clinical multimodal therapy for patients with anaplastic thyroid cancer to evaluate its effect on improving the survival of patients with anaplastic thyroid cancer at different stages.
Insights
Anaplastic thyroid cancer (ATC) remains a lethal malignancy with poor outcomes. Multimodal therapy shows promise in improving survival rates for ATC patients across different stages.
Area of Science:
- Oncology
- Cancer Research
- Thyroid Cancer
Background:
- Anaplastic thyroid cancer (ATC) is a highly aggressive malignancy with a dismal prognosis.
- Current treatments including surgery, radiotherapy, and chemotherapy offer suboptimal outcomes.
- Limited effective therapeutic options necessitate the exploration of novel treatment strategies.
Purpose of the Study:
- To evaluate the efficacy of multimodal therapy in improving survival rates for patients with anaplastic thyroid cancer.
- To assess the impact of multimodal therapy on anaplastic thyroid cancer prognosis across various disease stages.
Main Methods:
- Retrospective analysis of clinical data from anaplastic thyroid cancer patients.
- Evaluation of multimodal therapy approaches in a real-world clinical setting.
Main Results:
- Multimodal therapy demonstrated potential in prolonging survival time for anaplastic thyroid cancer patients.
- Improved prognosis was observed in patients receiving multimodal treatment, with variations across different stages.
Conclusions:
- Multimodal therapy represents a promising strategy for enhancing survival and prognosis in anaplastic thyroid cancer.
- Further research and clinical application of multimodal therapy are warranted for this aggressive cancer.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...